GenMark Expects to File Respiratory Virus, CYP2C19 Tests with FDA in 2012
November 15, 2011
GenMark Expects to File Respiratory Virus, CYP2C19 Tests with FDA in 2012
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Array-Based Tests Advance as Dx Firms Engage FDA, Raise Capital, Report Revenue Growth
May 15, 2012 / BioArray News - GenMark Plans to Expand Test Menu, Debut Next-Gen System in 2013
August 9, 2011 / BioArray News - GenMark Dx Plans Respiratory Viral, CYP450 Panels as Q2 Revenues Rise 162 Percent
August 10, 2010 / BioArray News - Q&A: INMEGEN's Alfredo Hidalgo on Using Genomics to Address Mexico's Most Pressing Health Problems
May 17, 2013 / BioArray News - Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News